For: | Ouranos K, Chatziioannou A, Goulis I, Sinakos E. Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation. World J Transplant 2022; 12(11): 331-346 [PMID: 36437845 DOI: 10.5500/wjt.v12.i11.331] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v12/i11/331.htm |
Number | Citing Articles |
1 |
Deyuan Zhong, Ying Shi, Wenzhe Ma, Yuxin Liang, Hanjie Liu, Yingying Qin, Lu Zhang, Qinyan Yang, Xiaolun Huang, Yuanjun Lu, Jin Shang. Single‐cell profiling reveals the metastasis‐associated immune signature of hepatocellular carcinoma. Immunity, Inflammation and Disease 2024; 12(5) doi: 10.1002/iid3.1264
|
2 |
Hirak Pahari, Amruth Raj, Ambreen Sawant, Dipak S Ahire, Raosaheb Rathod, Chetan Rathi, Tushar Sankalecha, Sachin Palnitkar, Vikram Raut. Liver transplantation for hepatocellular carcinoma in India: Are we ready for 2040?. World Journal of Transplantation 2024; 14(1): 88833 doi: 10.5500/wjt.v14.i1.88833
Abstract(241) |
Core Tip(229) |
Full Article(HTML)(1070)
|
Full Article with Cover (PDF)-1708K(38)
|
Audio-874K(2)
|
Peer-Review Report-194K(23)
|
Answering Reviewers-170K(26)
|
Supplementary Material-181K(25)
|
Full Article (PDF)-1362K(71)
|
Full Article (XML)-204K(26)
|
Times Cited (0)
|
Total Visits (2866)
|
Open
|
3 |
Yi-Jie Zhang, Dian-Jie Zhou, Hong Li, Qi Pan, Ying Cheng. Prolongated and large dose of r-ATG relieves PD-L1 inhibitor-induced allograft rejection in liver transplant recipient. Hepatobiliary & Pancreatic Diseases International 2024; doi: 10.1016/j.hbpd.2024.05.005
|
4 |
Claudia R. Silver, Cynthia De la Garza-Ramos, John A. Stauffer, Umair Majeed, Jianfeng Wang, Beau B. Toskich. Ipilimumab and nivolumab plus radioembolization as salvage therapy for atezolizumab and bevacizumab refractory hepatocellular carcinoma resulting in complete pathologic response. Radiology Case Reports 2024; 19(11): 5024 doi: 10.1016/j.radcr.2024.07.157
|